We are live on
!
Find out more
GCM
Gables Capital Management Portfolio holdings
AUM
$236M
1-Year Est. Return
32.91%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+32.91%
3 Year Est. Return
+123.38%
5 Year Est. Return
+165.74%
10 Year Est. Return
–
AUM
$207M
AUM Growth
+$9.1M
(+4.6%)
Cap. Flow
+$1.34M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
38.85%
Holding
454
New
8
Increased
40
Reduced
71
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$914K |
| 2 |
Boeing
BA
|
+$478K |
| 3 |
Eli Lilly
LLY
|
+$414K |
| 4 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$334K |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$295K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$331K |
| 2 |
Chipotle Mexican Grill
CMG
|
+$283K |
| 3 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$208K |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$152K |
| 5 |
Dell
DELL
|
+$119K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.64% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 11.28% |
| 4 | Healthcare | 9.62% |
| 5 | Industrials | 8.76% |
Similar funds
RP
CWL
WW
TCM
PVM
JRPCML
CF
BCM
Gables Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Gables Capital Management held 454 positions worth $207M, up 4.6% from $198M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.7%. Gables Capital Management opened 8 new positions and exited 9, leaving the 454-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Gables Capital Management's largest Q4 2024 buy was iShares MSCI ACWI ex US ETF: 6,100 shares worth $318K.
- Gables Capital Management added most to Apple in Q4 2024, an estimated $914K increase.
- Gables Capital Management's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $331K.
- Gables Capital Management fully exited Outlook Therapeutics in Q4 2024, selling an estimated $58.6K.
- Gables Capital Management's ten largest holdings make up 39% of its $207M portfolio in Q4 2024.
- Gables Capital Management opened 8 new positions and closed 9 in Q4 2024.
- Gables Capital Management's portfolio value rose 4.6% quarter-over-quarter to $207M.
Based on Gables Capital Management's 13F filing for Q4 2024, filed 7 Feb 2025.